Recruiting
Phase 2

Venetoclax for the Treatment of Patients With Relapsed Hairy Cell Leukemia

Sponsor:

National Cancer Institute (NCI)

Code:

NCT06311227

Conditions

Recurrent Hairy Cell Leukemia

Recurrent Hairy Cell Leukemia Variant

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Bone Marrow Aspiration

Bone Marrow Biopsy

Computed Tomography

Magnetic Resonance Imaging

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information